NutriBand Files 10-Q, Maintains Compliance as Emerging Growth Company

TL;DR

NutriBand's 10-Q shows basic compliance, but as a smaller reporting company, investors should dig deeper for financial performance beyond this initial regulatory check.

AI Summary

NutriBand Inc. (NTRBW) filed its 10-Q for the quarter ended April 30, 2025, indicating it is a non-accelerated filer, a smaller reporting company, and an emerging growth company. The company's primary business is in orthopedic, prosthetic, and surgical appliances and supplies. While specific revenue and net income figures are not provided in the initial excerpt, the filing confirms compliance with SEC reporting requirements, having filed all reports required by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months. NutriBand Inc. also confirmed electronic submission of all Interactive Data Files required by Rule 405 of Regulation S-T. The company's common stock trades under NTRB and warrants under NTRBW on The Nasdaq Stock Market LLC. The company's business address is 121 S. Orange Ave., Suite 1500, Orlando, FL 32801, with a phone number of 407-377-6695.

Why It Matters

This filing confirms NutriBand Inc.'s ongoing compliance with SEC regulations, which is crucial for investor confidence and market transparency. As a smaller reporting and emerging growth company, NTRBW faces less stringent reporting requirements, potentially impacting the depth of information available to investors compared to larger competitors. For employees and customers, continued regulatory adherence signals stability. In the competitive orthopedic and surgical supplies market, maintaining good standing with regulators is a baseline expectation, and any lapse could severely damage its market position against established players.

Risk Assessment

Risk Level: medium — The risk level is medium because while NutriBand Inc. is compliant with SEC filing requirements, its status as a 'smaller reporting company' and 'emerging growth company' suggests it may have fewer resources or a less established financial history than larger, more mature companies. This status often correlates with higher volatility and less comprehensive public disclosures, increasing investor risk.

Analyst Insight

Investors should view this filing as a procedural update and not a financial performance indicator. Further due diligence is required to assess NutriBand's financial health, competitive landscape, and growth prospects, especially given its 'smaller reporting company' status.

Key Numbers

• 001-40854 — SEC File Number (identifies NutriBand's registration with the SEC)
• 81-1118176 — IRS Employer Identification No. (NutriBand's tax identification number)
• 3842 — Standard Industrial Classification (identifies NutriBand's industry as Orthopedic, Prosthetic & Surgical Appliances & Supplies)

Key Players & Entities

• NutriBand Inc. (company) — registrant for 10-Q filing
• SEC (regulator) — Securities and Exchange Commission
• The Nasdaq Stock Market LLC (company) — exchange where NTRB and NTRBW are traded
• NTRBW (company) — trading symbol for warrants
• NTRB (company) — trading symbol for common stock
• Nevada (person) — state of incorporation
• Orlando, FL (person) — principal executive offices location
• 407-377-6695 (person) — registrant's telephone number
• April 30, 2025 (person) — end of quarterly period reported
• May 30, 2025 (person) — filing date of 10-Q

FAQ

Industry Context

NutriBand Inc. operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry (SIC 3842). This sector is characterized by innovation in medical device technology, driven by an aging population and increasing demand for minimally invasive procedures. Competition can be intense, with established players and emerging companies vying for market share through product development and strategic partnerships.

Regulatory Implications

As a non-accelerated filer and smaller reporting company, NutriBand Inc. benefits from scaled disclosure requirements. However, it must continue to comply with all SEC reporting obligations, including the electronic submission of Interactive Data Files. Any failure to meet these requirements could lead to regulatory scrutiny and potential penalties.

What Investors Should Do

1. Review the full 10-Q filing for detailed financial statements and management's discussion and analysis.
2. Monitor future filings for revenue and profitability trends, especially in relation to the company's stated business in orthopedic, prosthetic, and surgical appliances.
3. Assess the company's cash position and debt levels once detailed financial statements are available.

Glossary

10-Q

A quarterly report filed by public companies with the U.S. Securities and Exchange Commission (SEC) that provides a comprehensive update on the company's financial performance and condition. (This document is the 10-Q filing for NutriBand Inc. for the quarter ended April 30, 2025, providing key financial and operational information.)

Non-accelerated filer

A classification for SEC registrants that do not meet the thresholds for accelerated or large accelerated filer status, typically indicating a smaller market capitalization. (NutriBand Inc. is classified as a non-accelerated filer, suggesting it is a smaller company in terms of market size.)

Smaller reporting company

An SEC classification for companies with a public float below a certain threshold, allowing for scaled disclosure requirements. (NutriBand Inc. is identified as a smaller reporting company, which may impact the extent of financial information required in its filings.)

Emerging growth company

A classification under the JOBS Act for companies with total annual gross revenues of less than $1 billion during their first fiscal year with a registered issuer, allowing for certain regulatory accommodations. (NutriBand Inc. is an emerging growth company, which may benefit from extended transition periods for new accounting standards.)

Interactive Data File

Electronic files submitted to the SEC in a machine-readable format (e.g., XBRL) that tag financial information, making it easier to analyze. (NutriBand Inc. confirmed it has submitted all required Interactive Data Files, indicating compliance with modern SEC electronic filing standards.)

Section 13 or 15(d) of the Securities Exchange Act of 1934

These sections of the Act mandate that public companies file periodic reports (like 10-Ks and 10-Qs) with the SEC to keep investors informed. (NutriBand Inc. confirmed it has filed all required reports under these sections for the preceding 12 months, demonstrating ongoing compliance.)

Year-Over-Year Comparison

As specific financial figures for the quarter ended April 30, 2025, are not detailed in this excerpt, a direct comparison to the previous year's filing cannot be made. However, the filing confirms NutriBand Inc.'s status as a non-accelerated filer, smaller reporting company, and emerging growth company, which are consistent classifications. Investors should refer to the full 10-Q to identify any changes in financial performance, risk factors, or strategic initiatives compared to prior periods.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 30, 2025 by Nevada regarding NutriBand Inc. (NTRBW).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR